Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor Journal Article


Authors: Taylor, J.; Donoghue, M. T. A.; Ho, C.; Petrova-Drus, K.; Al-Ahmadie, H. A.; Funt, S. A.; Zhang, Y.; Aypar, U.; Rao, P.; Chavan, S. S.; Haddadin, M.; Tamari, R.; Giralt, S.; Tallman, M. S.; Rampal, R. K.; Baez, P.; Kappagantula, R.; Kosuri, S.; Dogan, A.; Tickoo, S. K.; Reuter, V. E.; Bosl, G. J.; Iacobuzio-Donahue, C. A.; Solit, D. B.; Taylor, B. S.; Feldman, D. R.; Abdel-Wahab, O.
Article Title: Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
Abstract: Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes. One in every 17 patients with primary mediastinal nonseminomatous GCTs develop an incurable hematologic malignancy and prior data intriguingly suggest a clonal relationship exists between hematologic malignancies and GCTs in these cases. To date, however, the precise clonal relationship between GCTs and the diverse additional somatic malignancies arising in such individuals have not been determined. Here, we traced the clonal evolution and characterized the genetic features of each neoplasm from a cohort of 15 patients with GCTs and associated hematologic malignancies. We discovered that GCTs and hematologic malignancies developing in such individuals evolved from a common shared precursor, nearly all of which harbored allelically imbalanced p53 and/or RAS pathway mutations. Hematologic malignancies arising in this setting genetically resembled mediastinal GCTs rather than de novo myeloid neoplasms. Our findings argue that this scenario represents a unique clinical syndrome, distinct from de novo GCTs or hematologic malignancies, initiated by an ancestral precursor that gives rise to the parallel evolution of GCTs and blood cancers in these patients. © 2020, American Society for Clinical Investigation.
Journal Title: Journal of Clinical Investigation
Volume: 130
Issue: 12
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2020-12-01
Start Page: 6668
End Page: 6676
Language: English
DOI: 10.1172/jci139682
PUBMED: 32897884
PROVIDER: scopus
PMCID: PMC7685753
DOI/URL:
Notes: Article -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Solit
    779 Solit
  2. Satish K Tickoo
    483 Tickoo
  3. Sergio Andres Giralt
    1050 Giralt
  4. Martin Stuart Tallman
    649 Tallman
  5. Darren Richard Feldman
    340 Feldman
  6. Raajit Kumar Rampal
    338 Rampal
  7. Victor Reuter
    1228 Reuter
  8. George Bosl
    430 Bosl
  9. Barry Stephen Taylor
    238 Taylor
  10. Roni Tamari
    208 Tamari
  11. Ahmet Dogan
    454 Dogan
  12. Samuel Aaron Funt
    135 Funt
  13. Satyajit   Kosuri
    28 Kosuri
  14. Caleb   Ho
    72 Ho
  15. Justin   Taylor
    51 Taylor
  16. Yanming Zhang
    199 Zhang
  17. Priscilla Baez
    9 Baez
  18. Shweta S Chavan
    34 Chavan
  19. Umut Aypar
    35 Aypar
  20. Pavitra Nagesh Rao
    4 Rao